These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17658373)

  • 1. Macular degeneration, patients' groups, and pharma.
    The Lancet
    Lancet; 2007 Jul; 370(9583):194. PubMed ID: 17658373
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new drug for macular degeneration. A breakthrough accomplished (interview by Waldtraud Paukstadt)].
    Holz FG
    MMW Fortschr Med; 2007 Jan; 149(3):13-4. PubMed ID: 17619376
    [No Abstract]   [Full Text] [Related]  

  • 3. AMD: out of sight out of mind.
    Pountney D
    Nurs Older People; 2007 Dec; 19(10):16-9. PubMed ID: 18220063
    [No Abstract]   [Full Text] [Related]  

  • 4. Bevacizumab and ranibizumab. Bevacizumab and the inverse postcode lottery.
    Harris MJ
    BMJ; 2010 Jul; 341():c3718. PubMed ID: 20627986
    [No Abstract]   [Full Text] [Related]  

  • 5. Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?
    Harvey KJ; Day RO; Campbell WG; Lipworth W
    Med J Aust; 2011 Jun; 194(11):567-8. PubMed ID: 21644867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of neovascular age-related macular degeneration: an unresolved matter].
    Flores-Moreno S; Bautista-Paloma J
    Arch Soc Esp Oftalmol; 2008 Jul; 83(7):405-6. PubMed ID: 18592439
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of exudative age-related macular degeneration: many factors to consider.
    Olsen TW
    Am J Ophthalmol; 2007 Aug; 144(2):281-3. PubMed ID: 17659955
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration.
    Hernandez-Pastor LJ; Ortega A; Garcia-Layana A; Giraldez J
    Clin Ther; 2008 Dec; 30(12):2436-51. PubMed ID: 19167602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Wiwanitkit V
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1675; author reply 1677. PubMed ID: 20424851
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of neovascular age-related macular degeneration with bevacizumab].
    Monzón Moreno A
    Farm Hosp; 2006; 30(6):387-8. PubMed ID: 17298199
    [No Abstract]   [Full Text] [Related]  

  • 11. A cost-effectiveness analysis of three treatments for age-related macular degeneration.
    Gower EW; Cassard SD; Bass EB; Schein OD; Bressler NM
    Retina; 2010 Feb; 30(2):212-21. PubMed ID: 19940805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The current state and issues of medical treatment for age-related macular degeneration].
    Ishida S
    Nihon Yakurigaku Zasshi; 2008 Jan; 131(1):47-9. PubMed ID: 18187884
    [No Abstract]   [Full Text] [Related]  

  • 13. [VEGF inhibitors in ophthalmology].
    Thys J; Dupont G; Rakic JM
    Rev Med Liege; 2009; 64(5-6):323-6. PubMed ID: 19642468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatments for age-related macular degeneration.
    Rosenfeld PJ
    Lancet; 2007 Oct; 370(9597):1479; author reply 1480. PubMed ID: 17964340
    [No Abstract]   [Full Text] [Related]  

  • 15. Bevacizumab in ophthalmology: the controversy moves forward.
    Gillies MC
    Clin Exp Ophthalmol; 2010 May; 38(4):333-4. PubMed ID: 20642588
    [No Abstract]   [Full Text] [Related]  

  • 16. Debate on the various anti-vascular endothelial growth factor drugs.
    Khalili MR; Hosseini H
    Indian J Ophthalmol; 2008; 56(3):255-6; author reply 256. PubMed ID: 18417837
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.
    Nelson M
    Retina; 2010 Feb; 30(2):380; author reply 380-1. PubMed ID: 20142719
    [No Abstract]   [Full Text] [Related]  

  • 18. A view on new drugs for macular degeneration.
    Drug Ther Bull; 2007 Jul; 45(7):49-52. PubMed ID: 17718304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vision for patients with macular degeneration].
    Paukstadt W
    MMW Fortschr Med; 2007 Jan; 149(3):10-2. PubMed ID: 17619375
    [No Abstract]   [Full Text] [Related]  

  • 20. New treatments for age-related macular degeneration.
    Avery RL
    Lancet; 2007 Oct; 370(9597):1479-80; author reply 1480. PubMed ID: 17964341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.